Pseudomonas aeruginosa (Schroeter) Migula B161482_ATCC代理_宁波明舟生物科技有限公司，细胞，菌株，ATCC，保藏中心

Pseudomonas aeruginosa (Schroeter) Migula

规格:

价格:

编号:B161482

品牌:Mingzhoubio

标准菌株

定量菌液

DNA

RNA

规格:

冻干粉

斜面

甘油

平板

加入购物车

在线咨询收藏

产品名称

Pseudomonas aeruginosa (Schroeter) Migula

商品货号

B161482

Reports

Upon your purchase of this product, you will receive a report containing MIC values, a susceptibility profile, and the DNA sequence information for predicted annotated antibiotic resistance genes and 16S rRNA genes. This report will be provided in multiple formats (.pdf, .txt, .xls, .zip).

Deposited As

Pseudomonas aeruginosa

培养基

Strain Designations

1109196

Application

Drug discovery and development
Development of molecular-based detection assays
Development of updated sterility protocols

Isolation

Endotrachial aspirate

Isolation Date

2014

Geographic Source

Colombia

Biosafety Level

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format

frozen

Storage Conditions

-80°C or colder

Preceptrol®

Annotated Genes

aadA
amrA
amrB
ANT2-Ia
APH(3')-IIb
catB7
KPC-2
macB
mexA
mexB
mexC
mexD
mexE
mexF
mexH
mexI
mexK
mexN
mexP
mexQ
mexV
mexW
msbA
muxB
muxC
oprM
OXA-2
OXA-50
PDC-2

Type Strain

MIC Range

Susceptible
Colistin: ≤2 µg/mL
Levofloxacin: ≥8 µg/mL

Resistant
Amikacin: ≥64 µg/mL
Aztreonam: ≥32 µg/mL
Cefepime: ≥32 µg/mL
Ceftazidime: ≥32 µg/mL
Ciprofloxacin: ≥4 µg/mL
Doripenem: ≥8 µg/mL
Imipenem: ≥8 µg/mL
Meropenem: ≥8 µg/mL
Piperacillin-tazobactam: ≥128/4 µg/mL

Comments

This strain is part of the Global Priority Superbugs collection. It is an extensively characterized antimicrobial-resistant clinical isolate with validated genotypic and phenotypic activity against a variety of drug classes. This strain is provided with geographic source information; an NGS-assembled whole genome sequence, including annotated antibiotic resistance and rRNA genes; and an expanded level of susceptibility data with MIC test results.

Minimum inhibitory concentration (MIC) ranges for resistant, intermediate, and susceptible are based on criteria within the Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing, 26^th Edition.

Predicted antimicrobial resistance gene sequence data are provided for informational purposes only and are based on open reading frames (ORFs) identified and annotated from contigs produced during next-generation sequencing (NGS). ATCC does not warrant that the entire predicted antimicrobial resistance gene is present within the sequence prepared for lot-specific reports. Likewise, the information provided merely indicates that some portion of the sequence (whole or in part) is present based on analytical base pair alignment with known gene sequences.

Medium

ATCC^® Medium 18: Trypticase Soy Agar/Broth

Growth Conditions

Temperature: 37°C
Atmosphere: Aerobic

Name of Depositor

International Health Management Associates (IHMA), Inc.

Special Collection

Global Priority Superbugs

Chain of Custody

ATCC <-- International Health Management Associates (IHMA), Inc.

Patient Age

Patient Gender

Male

References

Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing, 26th Edition. Wayne, PA. M100S, 2016.

B244973：Pseudomonas aeruginosa (Schroeter) Migula

B244926：Pseudomonas syringae van Hall pathovar myricae

B244792：Pseudomonas syringae van Hall pathovar morsprunorum

B244590：Pseudomonas sp.

B244584：Pseudomonas savastanoi (Smith) Gardan et al.

王经理

手机号：17280875617

QQ：1438578920
胡经理

手机号：13345964880

QQ：2438244627
周经理

手机号：17757487661

QQ：1296385441
于经理

手机号：18067160830

QQ：2088210172
沈经理

手机号：19548299266

QQ：2662369050
李经理

手机号：13626845108

QQ：972239479